Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery (Series C Book 2)

  • NH_0000004835
15 $

by Larry H. Bernstein (Author), Demet Sag (Author), Dror Nir (Author), Ziv Raviv (Author), Danut Dragoi (Author), Evelina Cohn (Author), 3 more

Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery (Series C Book 2)

by Larry H. Bernstein (Author), Demet Sag (Author), Dror Nir (Author), Ziv Raviv (Author), Danut Dragoi (Author), Evelina Cohn (Author), 3 more

This e-Book is a comprehensive review and interpretation of recent Original Research on Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery written by Experts, Authors, Writers. The results of Frontier Original Research are gaining value added for the e-Reader by the Methodology of Curation. The e-Book’s articles have been published on the Open Access Online Scientific Journal, http://pharmaceuticalintelligence.com since April 2012. All new articles on this subject, will continue to be incorporated, as published with periodical updates inserted to the articles in the Journal The e-Book has an abbreviated electronic Table of Contents (eTOCs) allowing for efficient e-Book Overview look-up. The eight parts of this e-Book are: Part One: Cancer Genomic and Metabolic Targeted Pharmacotherapy
Part Two: Interventional Oncology
Part Three: Immunotherapy, Biologics Drugs Options & Targeted Therapies for the Immune System of the Cancer Patient
Part Four: Hormonal Therapies
Part Five: Alternative Therapies
Part Six: NanoTechnology, Nanoparticles and Drug Delivery
Part Seven: Transitional Stages of Cancer
Part Eight: Research & Future Directions for Cancer Therapy and Prevention

 

Product details

  • File Size: 30345 KB
  • Print Length: 5408 pages
  • Publisher: Leaders in Pharmaceutical Business Intelligence (LPBI) Group; 1 edition (May 13, 2017)
  • Publication Date: May 13, 2017